Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Главные авторы: Xiang Tong (Автор), Shijie Zhang (Автор), Dongguang Wang (Автор), Li Zhang (Автор), Jizheng Huang (Автор), Tianli Zhang (Автор), Hong Fan (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...